地塞米松缓释微粒在增生性玻璃体视网膜病变的应用

目的：观察含地塞米松（DEX）的缓释微粒治疗增生性玻璃体视网膜病变（PVR）的临床疗效。方法：9例（9只眼）视网膜脱离伴PVR患者进行常规玻璃体视网膜手术，并在玻璃体腔内植入1粒DEX微粒（含地塞米松1mg），观察术后反应及视力、PVR发展、DEX的位置及形状变化等。结果：术后炎症反应轻，7只眼视网膜复位，3只眼后极部视网膜前有增生；2只眼视网膜局限性脱离，最终3只眼玻璃腔内硅油填充。随访视力有8只眼较术前提高（P=0.015）。DEX未见对视网膜有不良影响，仅在随着处有少量色素吸附，4-6月后吸收。结论：DEX抑制PVR术后炎症反应及较远期作用是安全、有效的；对手术未完全清除的视网膜前增生有一定的抑制作用。     

心痛灵喷雾剂抗心肌缺血的实验观察

①目的　观察心痛灵喷雾剂对心肌缺血大鼠的药理作用。②方法　通过结扎大鼠冠状动脉前降支制备大鼠心肌缺血模型 ,观察心痛灵喷雾剂对心肌缺血面积和血清磷酸肌酸激酶 (CK)、乳酸脱氢酶 (LDH)、谷草转氨酶 (GOT)的影响 ;静脉注射垂体后叶素制备大鼠心肌缺血模型 ,观察心痛灵喷雾剂对心电图改变的影响。③结果　心痛灵喷雾剂可减少心肌缺血大鼠心肌梗死面积 ,降低血清CK、LDH、GOT活性 ,并减轻静脉注射垂体后叶素引起的缺血性心电图改变 (tD=1.2 2 3～ 13.890 ,P <0 .0 5、0 .0 1)。④结论　心痛灵喷雾剂具有抗心肌缺血的作用     

吴(大士)药签选方用药特点探析

北宋名医吴本的精湛医术和高尚医德在漳州、泉州和台南民众中久为传颂，流感在慈济宫的“济世仙方药鉴”是现存有关吴本的宝贵医药资料，该药签体现了中医的选方特点和用药特点，今天仍有整理研究的价值。     

Tubulointerstitial nephritis caused by the antiviral agent foscarnet

The antiviral agent foscarnet has long been used in our unit to treat cytomegalovirus (CMV) infections in renal transplant patients. The clinical effect has been convincing and, apart from changes in serum calcium levels, very few side effects have been noted. We have, however, observed a nephrotoxic reaction in a series of patients with initially good renal function who therefore received high doses of foscarnet. Transplant biopsies performed in five of those patients revealed degenerative changes in the tubular epithelial cells as well as tubular calcium deposits and an infiltration of the interstitium by mixed mononuclear and polymorphonuclear leucocytes. Renal insufficiency was accompanied by high fever. After withdrawal of the drug, the temperature rapidly normalized, whereas serum creatinine continued to rise for about 3 days and then fell back towards previous levels. We conclude that transplant biopsies are of great value in distinguishing between a foscarnet nephrotoxic effect and CMV nephritis, various forms of rejection, and other causes of impaired renal function.     

改进时间差攻击疗法治疗多重耐药阴沟肠杆菌的探究

[目的]研究利用改进的时间攻击疗法治疗多重耐药阴沟肠杆菌引起的感染的效果，并考究其与亚胺培南/西拉司丁治疗及传统时间攻击疗法的药物经济学成本/效果比。[方法]将38例明确诊断为产ESBLs阴沟肠杆菌感染且药敏结果皆为：对哌拉西林、环丙沙星、氧氟沙星、左旋氧氟沙星、庆大霉素、妥布霉素、头孢他啶、头孢噻肟、头孢哌酮、头孢曲松、头孢哌酮/舒巴坦、替卡西林/克拉维酸等皆耐药，而对亚胺培南/西拉司丁敏感的患者随机分为改进组、对照组、传统组。改进组患者先与磷霉素4g＋5%葡萄糖100ml于30min静脉滴注完毕后，再过30min立即给予阿米卡星0.4g＋0.9%NS250ml静脉滴注，上述治疗每日1次。对照组患者给予亚胺培南/西拉司丁1g＋0.9%NS250ml静脉滴注，每日3次。传统组患者先与磷霉素2g＋5%葡萄糖50ml静脉给予1h完毕后，立即给予阿米卡星0.2g＋0.9%NS100ml静脉滴注，上述治疗每日2次。疗程最长限为10d，其余检查治疗3组相同。考察3组的细菌清除率以及细菌清除所需的药物费用、不良反应的比较。[结果]改进组细菌清除率与对照组、传统组差异无统计学意义，并且改进组、传统组无不良反应，对照组有1例二重感染；而且改进组与对照组、传统组的细菌清除药物治疗费用差异有统计学意义。[结论]利用磷霉素＋阿米卡星的改进时间攻击差疗法能很好的治疗多重耐药的阴沟肠杆菌引起的感染，并且与采用亚胺培南/西拉司丁治疗方案及传统的时间攻击疗法相比具有较好的成本/效果比。     

人源化CD33单克隆抗体联合化疗与单用化疗在初次复发或难治性急性髓性白血病治疗中比较的Ⅲ期多中心随机研究的评价

4背景 CD33是一种细胞表面的受体，它只存在于粒单细胞表面。体外研究表明，抗CD33抗体与受体结合后导致了剂量依赖性的细胞凋亡．这与其他抗体如CD22在淋巴系统恶性肿瘤中的方式是相似的。由于CD33在急性髓性白血病（acute myeloid leukemia，AML）的幼稚细胞中广泛表达（〉90％），而在大多数的非血液系统的组织则不表达．故针对CD33的抗体类药物．如联合了刺孢霉素的抗CD33抗体吉姆单抗奥佐米星（Gemtuzumab Ozogamicin，GO）已用于治疗AML的病人。     

A comparison of the effects of a macrobiotic diet and a western diet on drug metabolism and plasma lipids in man

Summary We have compared the effects of two dietary regimens with different macronutrient compositions — a macrobiotic diet and a Western diet — on drug metabolism and plasma lipids in seven healthy volunteers.The macrobiotic diet, high in carbohydrate, low in protein and fat, and devoid of animal food sources, was eaten for a ten day control period, as was the Western diet, high in calories, fat, and protein, as well as animal food sources. We determined the influences of these diets on the clearance of orally administered antipyrine, oxazepam, and methadone, as well as on plasma lipids.There was a statistically significant change in antipyrine clearance as well as in plasma LDL-cholesterol and HDL-cholesterol after the dietary periods. This suggests that the influence of dietary changes may have some effect on the clearance of therapeutic drugs. However, this is not universal and is probably important when the drug is highly dependent on the mixed-function oxidase system.     

羟基磷灰石义眼台作为药物缓释载体减轻术后反应的临床观察

目的评价羟基磷灰石（HA）义眼台作为药物缓释载体减轻眼球摘除义眼台植入术后反应的效果。方法植入HA义眼台前，用地塞米松5mg，庆大霉素8万u，透明质酸酶1500U混合液浸泡HA义眼台15—20min后植入，手术步骤按常规。结果观察术后1周反应情况，52例中51例（98．07％）无疼痛或仅有轻度疼痛；44例（84．62％）结膜无水肿；36例（69．23％）无恶心；16例（30．77％）轻中度恶心；48例（92．31％）无呕吐。与对照组（43例）比较，术后疼痛、结膜水肿、恶心呕吐均较轻，其差别均有统计学意义（P〈0．001）。结论HA义眼台作为药物缓释载体植入眼球肌膜囊内能有效地控制术后反应，减轻患者痛苦。     

Should harm minimization as an approach to adolescent substance use be embraced by junior and senior high schools?: Empirical evidence from An integrated school- and community-based demonstration intervention addressing drug use among adolescents

The objective of this demonstration project was to determine if school-based harm minimization drug education was potentially acceptable and effective for junior and senior high school students in Nova Scotia. We conducted a four-year quasi-experimental intervention using mixed quantitative and qualitative methodologies. The intervention was a co-operative participatory research project with various activities determined by the participants. The project involved a partnership of four schools, two school boards, two regional addiction services, the provincial department of health, and a university. The outcomes evaluation was based on a sample of 1117 and 849 students in the intervention schools, compared with 3755 and 4247 students in the rest of the province, in 1998 and 2002, respectively. The evaluation of acceptability was based on an analysis of 491 documents generated from 1998 to 2002. The outcomes of effectiveness were specific risks and harmful consequences associated with substance use. We found that harm minimization was an acceptable approach to drug education targeting the senior high school population, and there was also some evidence of effectiveness in that age group in that the prevalence of several risks and negative consequences of substance use decreased significantly in the intervention schools relative to the rest of the province. In junior high school, harm minimization was found to not be an acceptable approach to drug education. This demonstration project provides evidence that school-based harm minimization may be acceptable and effective in senior high schools but may not be acceptable in junior high schools.     

儿童地高辛血药浓度的回顾性分析

目的 :探讨血药浓度监测对个体化、合理化用药的重要作用。方法 :荧光偏振免疫法 (FPIA)和通过近十年住院病人地高辛用药的回顾性分析。结果 :地高辛血药浓度监测结果分三个范围 :低值小于 0 .8μg/ L,中值 0 .8～ 2 .2 μg/ L,高值大于 2 .2μg/ L。对实验数据进行统计 ,得出有效浓度范围内的病人占 4 0 %左右 ,低值平均约 >5 0 % ,高值平均为 6 .1%。结论 :通过对地高辛用药的监测回顾 ,说明地高辛的药物代谢过程受许多因素如吸收、分布、代谢、排泄、药物间的相互作用等的影响。所以临床在用药过程中 ,药物浓度的监测对实施个体化、合理化用药 ,减少药物中毒的发生起着重要作用